GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance

Canadian Markets closed

Gilead Sciences, Inc. (GILD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
68.55-0.03 (-0.04%)
At close: 4:00PM EDT
People also watch
CELGBIIBAMGNBMYREGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close68.58
Open68.83
Bid68.50 x 100
Ask69.00 x 200
Day's Range68.24 - 68.96
52 Week Range65.38 - 89.45
Volume5,301,143
Avg. Volume9,701,496
Market Cap89.61B
Beta0.99
PE Ratio (TTM)6.90
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (3.05%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube16 hours ago

    Gilead Sciences, Inc. – Value Analysis (NASDAQ:GILD) : April 28, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Gilead Sciences, Inc. a score of 66. Our analysis is based on comparing Gilead Sciences, Inc. with the following peers – Amgen Inc., Vertex Pharmaceuticals Incorporated, Celgene Corporation, Alexion Pharmaceuticals, Inc., AbbVie, Inc., Biogen Inc., Illumina, Inc., Eli Lilly and Company, Pfizer Inc. and Johnson & Johnson ... Read more (Read more...)

  • Bristol-Myers Beats Gilead, Merck To Key Approvals In China, Europe
    Investor's Business Daily17 hours ago

    Bristol-Myers Beats Gilead, Merck To Key Approvals In China, Europe

    Bristol-Myers grabbed a pair of wins Friday after China approved its hepatitis C regimen and Europe blessed immuno-oncology drug Opdivo in head-and-neck cancer.

  • The Tech Sector's Strong Earnings Power
    Zacks19 hours ago

    The Tech Sector's Strong Earnings Power

    The Tech Sector's Strong Earnings Power